Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines.
Fuentes-Baile M, Ventero MP, Encinar JA, García-Morales P, Poveda-Deltell M, Pérez-Valenciano E, Barberá VM, Gallego-Plazas J, Rodríguez-Lescure Á, Martín-Nieto J, Saceda M. Fuentes-Baile M, et al. Among authors: gallego plazas j. Cancers (Basel). 2020 Dec 11;12(12):3717. doi: 10.3390/cancers12123717. Cancers (Basel). 2020. PMID: 33322337 Free PMC article.
HGUE-C-1 is an atypical and novel colon carcinoma cell line.
Grasso S, Martínez-Lacaci I, Barberá VM, Castillejo A, Soto JL, Gallego-Plazas J, López-Riquelme N, García-Morales P, Mata-Balaguer T, Ferragut JA, Saceda M. Grasso S, et al. BMC Cancer. 2015 Apr 8;15:240. doi: 10.1186/s12885-015-1183-3. BMC Cancer. 2015. PMID: 25885658 Free PMC article.
Intramedullary metastases due to non microcytic lung carcinoma.
Maciá Escalante S, Martínez Ortiz MJ, Guillén Ponce C, Rodríguez Lescure A, Gallego Plazas J, Carrato Mena A. Maciá Escalante S, et al. Clin Transl Oncol. 2006 Jun;8(6):459-60. doi: 10.1007/s12094-006-0203-9. Clin Transl Oncol. 2006. PMID: 16790402 No abstract available.
Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapy.
Custodio A, Moreno-Rubio J, Aparicio J, Gallego-Plazas J, Yaya R, Maurel J, Rodríguez-Salas N, Burgos E, Ramos D, Calatrava A, Andrada E, Díaz-López E, Sánchez A, Madero R, Cejas P, Feliu J. Custodio A, et al. Mol Cancer Ther. 2014 Sep;13(9):2226-37. doi: 10.1158/1535-7163.MCT-13-1109. Epub 2014 Jun 30. Mol Cancer Ther. 2014. PMID: 24980946
32 results